193 related articles for article (PubMed ID: 19593191)
1. Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study.
Derijks HJ; Janknegt R; Heerdink ER; De Koning FH; Krekels MM; Looij BJ; Egberts AC
J Clin Psychopharmacol; 2009 Aug; 29(4):405-8. PubMed ID: 19593191
[No Abstract] [Full Text] [Related]
2. Impact of sertraline on weight, waist circumference and glycemic control: A prospective clinical trial on depressive diabetic type 2 patients.
Rachdi C; Damak R; Fekih Romdhane F; Ouertani H; Cheour M
Prim Care Diabetes; 2019 Feb; 13(1):57-62. PubMed ID: 30287230
[TBL] [Abstract][Full Text] [Related]
3. Glycemic control improvement through treatment of depression using antidepressant drugs in patients with diabetes mellitus type 1.
Komorousova J; Beran J; Rusavy Z; Jankovec Z
Neuro Endocrinol Lett; 2010; 31(6):801-6. PubMed ID: 21196929
[TBL] [Abstract][Full Text] [Related]
4. Should the target A1C level be less than 7 percent? No: The case for modest glycemic control in patients with type 2 diabetes.
Barry HC
Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316991
[No Abstract] [Full Text] [Related]
5. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
Mullins CD; Shaya FT; Meng F; Wang J; Harrison D
Pharmacotherapy; 2005 May; 25(5):660-7. PubMed ID: 15899727
[TBL] [Abstract][Full Text] [Related]
6. Should the target A1C level be less than 7 percent? Yes: This should be the target for most patients.
Peterson K
Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316992
[No Abstract] [Full Text] [Related]
7. Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus.
de Groot M; Jacobson AM; Samson JA; Welch G
J Psychosom Res; 1999 May; 46(5):425-35. PubMed ID: 10404477
[TBL] [Abstract][Full Text] [Related]
8. [Control of diabetes mellitus].
Daweke H
Verh Dtsch Ges Inn Med; 1990; 96():175-82. PubMed ID: 2092437
[No Abstract] [Full Text] [Related]
9. Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial.
Paile-Hyvärinen M; Wahlbeck K; Eriksson JG
BMC Fam Pract; 2003 May; 4():7. PubMed ID: 12747810
[TBL] [Abstract][Full Text] [Related]
10. Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis.
Hieronymus F; Lisinski A; Nilsson S; Eriksson E
Lancet Psychiatry; 2019 Sep; 6(9):745-752. PubMed ID: 31303567
[TBL] [Abstract][Full Text] [Related]
11. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.
Klonoff DC; Kerr D
J Diabetes Sci Technol; 2017 Nov; 11(6):1063-1069. PubMed ID: 28884599
[No Abstract] [Full Text] [Related]
12. Improvement of Glycemic Control in Insulin-Dependent Diabetics with Depression by Concomitant Treatment with Antidepressants.
Radojkovic J; Sikanic N; Bukumiric Z; Tadic M; Kostic N; Babic R
Med Sci Monit; 2016 Jun; 22():2133-43. PubMed ID: 27329213
[TBL] [Abstract][Full Text] [Related]
13. Cognitive Behavioral Therapy Versus Sertraline in Patients With Depression and Poorly Controlled Diabetes: The Diabetes and Depression (DAD) Study: A Randomized Controlled Multicenter Trial.
Petrak F; Herpertz S; Albus C; Hermanns N; Hiemke C; Hiller W; Kronfeld K; Kruse J; Kulzer B; Ruckes C; Zahn D; Müller MJ
Diabetes Care; 2015 May; 38(5):767-75. PubMed ID: 25690005
[TBL] [Abstract][Full Text] [Related]
14. [Clinical aspects of Insulin Lispro (LY275585)].
Kuzuya T
Nihon Rinsho; 1997 Nov; 55 Suppl():298-305. PubMed ID: 9434484
[No Abstract] [Full Text] [Related]
15. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
Sun Y; Liang Y; Jiao Y; Lin J; Qu H; Xu J; Zhao C
BMJ Open; 2017 Aug; 7(8):e016499. PubMed ID: 28775189
[TBL] [Abstract][Full Text] [Related]
16. Glycemic Tracking Before and After Insulin Pump Initiation.
Johnson A; Hill NE; Godsland I; Oliver NS
J Diabetes Sci Technol; 2020 Sep; 14(5):970-971. PubMed ID: 32146846
[No Abstract] [Full Text] [Related]
17. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
Lustman PJ; Clouse RE; Nix BD; Freedland KE; Rubin EH; McGill JB; Williams MM; Gelenberg AJ; Ciechanowski PS; Hirsch IB
Arch Gen Psychiatry; 2006 May; 63(5):521-9. PubMed ID: 16651509
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant treatment strategy with an early onset of action improves the clinical outcome in patients with major depressive disorder and high anxiety: a multicenter and 6-week follow-up study.
Liao XM; Su YA; Wang Y; Yu X; Si TM
Chin Med J (Engl); 2020 Mar; 133(6):726-728. PubMed ID: 32097208
[No Abstract] [Full Text] [Related]
19. Intensive Glycemic Control in Type 2 Diabetes Mellitus -- A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment.
Rodriguez-Gutierrez R; Lipska KJ; McCoy RG
JAMA Intern Med; 2016 Mar; 176(3):300-1. PubMed ID: 26882223
[No Abstract] [Full Text] [Related]
20. Assessment of glycemic variability in continuous subcutaneous insulin infusion therapy in type 1 diabetes related to anthropometry and complication status.
Mehdi SK; Hatfield E; Dornhorst A; Oliver NS
J Diabetes Sci Technol; 2009 Sep; 3(5):1227-8. PubMed ID: 20144442
[No Abstract] [Full Text] [Related]
[Next] [New Search]
